Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: routine evidence from the Italian MASTER Cohort
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Mattia Prosperi Annalisa Saracino |
| Publication date | November 11, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |